Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

CAP: Commutative algebra prediction of protein-nucleic acid binding affinities.

Created on 15 Sep 2026

Authors

Mushal Zia, Faisal Suwayyid, Yuta Hozumi, JunJie Wee, Hongsong Feng, Guo-Wei Wei

Published in

Machine learning: science and technology. Volume 6. Issue 4. Epub Dec 17, 2025.

Abstract

An accurate prediction of protein-nucleic acid binding affinity is vital for deciphering genomic processes, yet existing approaches often struggle in reconciling high accuracy with interpretability and computational efficiency. In this study, we introduce commutative algebra prediction (CAP) framework, which couples persistent Stanley-Reisner theory with advanced sequence embedding for predicting protein-nucleic acid binding affinities. CAP encodes proteins through transformer-learned embeddings that retain long-range evolutionary context, and represents DNA and RNA with k-mer algebra embeddings derived from persistent facet ideals, which capture fine-scale nucleotide geometry. We demonstrate that CAP surpasses the SVSBI protein-nucleic acid benchmark and, in a further test, maintains reasonable performance on newly curated protein-RNA and protein-nucleic acid datasets. Leveraging only primary sequences, CAP generalizes to any protein-nucleic acid pair with minimal preprocessing, enabling genome-scale analyses without 3D structural data and promising faster virtual screening for drug discovery and protein engineering.

PMID:
41867886
Bibliographic data and abstract were imported from PubMed on 15 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement